UNICREDIT BANK/PUT/INTUITIVE SURGICAL/400/0.1/18.12.24 Share Price

Warrant

DE000HD5J215

Market Closed - BOERSE MUENCHEN 20:40:59 05/07/2024 BST
1.37 EUR -14.38% Intraday chart for UNICREDIT BANK/PUT/INTUITIVE SURGICAL/400/0.1/18.12.24
Current month-10.46%
1 month-39.65%
Date Price Change
05/07/24 1.37 -14.38%
04/07/24 1.6 0.00%
03/07/24 1.6 +5.96%
02/07/24 1.51 -9.58%
01/07/24 1.67 +9.15%

Real-time BOERSE MUENCHEN

Last update July 05, 2024 at 08:40 pm

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying INTUITIVE SURGICAL, INC.
IssuerLogo Issuer UniCredit UniCredit
WKN HD5J21
ISINDE000HD5J215
Date issued 13/05/2024
Strike 400 $
Maturity 18/12/2024 (166 Days)
Parity 10 : 1
Emission price 3.52
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 3.72
Lowest since issue 1.37
Delta-0.24x
Omega 7.164
Premium13.2x
Gearing29.99x
Moneyness 0.9014
Difference Strike -43.76 $
Difference Strike %-10.94%
Spread 0.03
Spread %2.17%
Theoretical value 1.365
Implied Volatility 31.55 %
Total Loss Probability 69.06 %
Intrinsic value 0.000000
Present value 1.365
Break even 385.20 €
Theta-0.05x
Vega0.09x
Rho-0.05x

Company Profile

Intuitive Surgical, Inc. specializes in the design, manufacturing, and marketing of robotic surgical assistance video systems. The systems consist of a surgical console, arm, remote-controlled endoscope, and 3D visual immersion system. Net sales break down by activity as follows: - sale of instruments and accessories (60%): primarily wrist cuffs; - sale of robotic systems (23.6%): systems marketed under the da Vinci brand (1,370 units sold in 2023) and intended primarily for urological, cardio-thoracic, and gynecological surgeries; - installation and training services (16.4%). The United States accounts for 65.8% of net sales.
Sector
-
More about the company

Ratings for Intuitive Surgical, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Intuitive Surgical, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
443.8 USD
Average target price
428.1 USD
Spread / Average Target
-3.53%
Consensus